Onconetix, Inc. Restricted Cash and Cash Equivalents
Onconetix, Inc. (ONCO) had Restricted Cash and Cash Equivalents of $21.26 million as of 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2023-05-12
- 2023-03-31: Restricted Cash and Cash Equivalents $21.26M.
- 2022-12-31: Restricted Cash and Cash Equivalents $25.75M.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2023-03-31 | $21.26M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $25.75M 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |